Observational Study on "Functional Overlay" in Patients With Movement Disorders
Trial
N/A
Recruiting
Sept. 28, 2025
Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)
Trial
N/A
Completed
Sept. 28, 2025
Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.
Trial
N/A
No longer available
Sept. 28, 2025
Novel Paradigms of Deep Brain Stimulation for Movement Disorders
Trial
N/A
Completed
Sept. 28, 2025
CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)
Trial
Phase 3
Completed
Sept. 28, 2025
Intermediate Size Expanded Access Protocol Using Autologous HB-adMSCs for the Treatment of Parkinson's Disease
Trial
N/A
No longer available
Sept. 28, 2025
A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease
Trial
Phase 3
Completed
Sept. 25, 2025
Rehabilitation of Airway Protection in Parkinson's Disease
Trial
Phase 2
Recruiting
Sept. 23, 2025
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease
Trial
Phase 1
Completed
Sept. 22, 2025
Consensus Statements on Deep Brain Stimulation in Patients With Parkinson's Disease
Trial
N/A
Not yet recruiting
Sept. 22, 2025
DBS Virtual Learning Experience
Trial
N/A
Active, not recruiting
Sept. 21, 2025
Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study
Trial
N/A
Recruiting
Sept. 21, 2025
Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease
Trial
N/A
Recruiting
Sept. 21, 2025
Physiotherapy and Deep Brain Stimulation in Parkinson's Disease
Trial
N/A
Active, not recruiting
Sept. 21, 2025
Brain-Machine Interface for Freezing of Gait
Trial
N/A
Enrolling by invitation
Sept. 21, 2025
The Benefits of Nature for Mood and Cognition in Persons With and Without Parkinson's Disease
Trial
N/A
Completed
Sept. 18, 2025
Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA
Trial
Phase 2
Withdrawn
Sept. 18, 2025
Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
Trial
N/A
Recruiting
Sept. 18, 2025
Deep Brain Stimulation and Parkinson's Disease
Trial
Early Phase 1
Completed
Sept. 18, 2025
Perception in Parkinson's Disease
Trial
N/A
Completed
Sept. 18, 2025